QTRX Logo

Quanterix Corporation (QTRX) 

NASDAQ
Market Cap
$450.95M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
121 of 774
Rank in Industry
14 of 99

Largest Insider Buys in Sector

QTRX Stock Price History Chart

QTRX Stock Performance

About Quanterix Corporation

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. The company also provides SP-X …

Insider Activity of Quanterix Corporation

Over the last 12 months, insiders at Quanterix Corporation have bought $831,730 and sold $112,405 worth of Quanterix Corporation stock.

On average, over the past 5 years, insiders at Quanterix Corporation have bought $1.5M and sold $7.79M worth of stock each year.

Highest buying activity among insiders over the last 12 months: WALT DAVID R (director) — $2.5M. Toloue Masoud (President & CEO) — $207,100.

The last purchase of 47,000 shares for transaction amount of $624,630 was made by WALT DAVID R (director) on 2024‑08‑20.

List of Insider Buy and Sell Transactions, Quanterix Corporation

2024-08-20Purchasedirector
47,000
0.1231%
$13.29$624,630-3.06%
2024-08-13PurchasePresident & CEO
19,000
0.0485%
$10.90$207,1000.00%
2024-05-14Saledirector
1,500
0.004%
$16.98$25,470-20.57%
2024-04-01Saledirector
1,000
0.0026%
$23.50$23,500-38.92%
2024-02-14Saledirector
1,500
0.004%
$24.35$36,525-36.95%
2024-01-02Saledirector
1,000
0.0026%
$26.91$26,910-39.55%
2023-09-08Purchasedirector
20,200
0.0545%
$24.85$501,978-9.38%
2022-08-12PurchasePresident & CEO
105,000
0.2829%
$10.43$1.1M+22.94%
2022-08-12PurchaseCFO and Treasurer
15,000
0.0394%
$10.16$152,418+22.94%
2022-08-11Purchase
4,760
0.0132%
$10.46$49,788+26.48%
2022-08-10Purchase
150,000
0.4084%
$8.62$1.29M+50.00%
2022-08-10Purchase
89,667
0.2385%
$8.43$755,543+50.00%
2022-08-10Purchase
47,957
0.1303%
$8.61$412,780+50.00%
2022-08-01SalePresident & CEO
446
0.0012%
$15.61$6,964-15.97%
2022-08-01SaleGeneral Counsel & Secretary
401
0.0011%
$15.61$6,261-15.97%
2022-07-13SaleCFO and Treasurer
434
0.0012%
$18.16$7,879-30.22%
2022-07-05SaleExecutive Chairman
960
0.0024%
$16.57$15,906-29.13%
2022-07-05SalePresident & CEO
432
0.0011%
$16.57$7,158-29.13%
2022-07-05SaleGeneral Counsel & Secretary
387
0.001%
$16.57$6,412-29.13%
2022-06-13SalePresident & CEO
5,564
0.0153%
$15.27$84,955-15.21%

Insider Historical Profitability

24.07%
WALT DAVID Rdirector
1487342
3.8754%
$11.7540+49.01%
Toloue MasoudPresident & CEO
354119
0.9227%
$11.7523+22.94%
CRANDELL KEITH
1537684
4.0066%
$11.7511<0.0001%
ARCH VENTURE FUND VI LP10 percent owner
1537684
4.0066%
$11.7510<0.0001%
HRUSOVSKY E KEVINExecutive Chairman
910249
2.3717%
$11.751103<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
BlackRock$73.57M8.163.12M-2.14%-$1.61M<0.01
AllianceBernstein$59.64M6.622.53M+351.8%+$46.44M0.02
Millennium Management LLC$53.37M5.922.27M+2.52%+$1.31M0.04
The Vanguard Group$48.76M5.412.07M+0.7%+$339,028.41<0.01
Lord Abbett$41.4M4.591.76M+22.85%+$7.7M0.15
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.